Medical Cannabis Access & Policy: A VA FOIA-based op-ed says internal VA rules now give clearer “bright line” guidance for how clinicians discuss medical cannabis with veterans, after years of uncertainty. Federal Coverage Fight: A U.S. House Appropriations vote would block federal workers’ compensation from covering medical marijuana, even after rescheduling. Market & Listings: Florida’s Trulieve is set to become the first U.S. cannabis company listed on the NYSE (NYSE: TRLV), a move tied to medical marijuana’s Schedule III reclassification. Clinical Research: A new randomized study reports medical marijuana extracts can meaningfully improve cancer-related sleep and anxiety symptoms for about half of patients, with benefits varying by individual cannabinoid preference. Regulation Watch: Texas smokable-hemp rules are back in effect after an appeals court denied an emergency injunction, though enforcement timing remains unclear. Public Safety & Enforcement: Europe’s drug watchdog warns synthetic opioids and new substances are spreading fast, with vapes flagged as a potential delivery route for harmful drugs. CBD in the Real World: A Venice canal inquest heard a tourist smoked CBD before falling in, underscoring how CBD use can still intersect with safety concerns. Business Expansion: High Tide opened a new Canna Cabana in Welland, Ontario, and plans another in Calgary. Compliance & Labor: South Africa’s crackdown at a Cape Town construction site found 79 undocumented workers, highlighting tightening enforcement around cannabis-adjacent labor and compliance risks.